Single-chain insulin
    1.
    发明授权
    Single-chain insulin 有权
    单链胰岛素

    公开(公告)号:US08883449B2

    公开(公告)日:2014-11-11

    申请号:US12251901

    申请日:2008-10-15

    CPC分类号: C07K14/62 A61K38/00

    摘要: The present invention is related to single-chain insulin having insulin activity comprising a B- and an A-chain or a modified B- and A-chain connected by a connecting peptide of from 6-11 amino acids. The single-chain insulins will have biological insulin activity and an IGF-1 receptor affinity similar to or lower than that of human insulin and a high physical stability. The single-chain insulin may contain at least one basic amino acid residues in the connecting peptide. The single-chain insulins may also be acylated in one or more Lys residues.

    摘要翻译: 本发明涉及具有胰岛素活性的单链胰岛素,其包含通过6-11个氨基酸的连接肽连接的B和A链或经修饰的B和A链。 单链胰岛素将具有与人胰岛素相似或更低的生物胰岛素活性和IGF-1受体亲和力,并具有高的物理稳定性。 单链胰岛素可以在连接肽中含有至少一个碱性氨基酸残基。 单链胰岛素也可以在一个或多个Lys残基中酰化。

    Single-chain insulin
    2.
    发明申请
    Single-chain insulin 审中-公开
    单链胰岛素

    公开(公告)号:US20070129284A1

    公开(公告)日:2007-06-07

    申请号:US11439897

    申请日:2006-05-24

    IPC分类号: A61K38/28 C07K14/62

    CPC分类号: C07K14/62 A61K38/00

    摘要: The present invention is related to single-chain insulin having insulin activity comprising a B- and an A-chain or a modified B- and A-chain connected by a connecting peptide of from 6-11 amino acids. The single-chain insulins will have biological insulin activity and an IGF-1 receptor affinity similar to or lower than that of human insulin and a high physical stability. The single-chain insulin may contain at least one basic amino acid residues in the connecting peptide. The single-chain insulins may also be acylated in one or more Lys residues.

    摘要翻译: 本发明涉及具有胰岛素活性的单链胰岛素,其包含通过6-11个氨基酸的连接肽连接的B和A链或经修饰的B和A链。 单链胰岛素将具有与人胰岛素相似或更低的生物胰岛素活性和IGF-1受体亲和力,并具有高的物理稳定性。 单链胰岛素可以在连接肽中含有至少一个碱性氨基酸残基。 单链胰岛素也可以在一个或多个Lys残基中酰化。

    Single-Chain Insulin
    3.
    发明申请
    Single-Chain Insulin 有权
    单链胰岛素

    公开(公告)号:US20090170750A1

    公开(公告)日:2009-07-02

    申请号:US12251901

    申请日:2008-10-15

    CPC分类号: C07K14/62 A61K38/00

    摘要: The present invention is related to single-chain insulin having insulin activity comprising a B- and an A-chain or a modified B- and A-chain connected by a connecting peptide of from 6-11 amino acids. The single-chain insulins will have biological insulin activity and an IGF-1 receptor affinity similar to or lower than that of human insulin and a high physical stability. The single-chain insulin may contain at least one basic amino acid residues in the connecting peptide. The single-chain insulins may also be acylated in one or more Lys residues.

    摘要翻译: 本发明涉及具有胰岛素活性的单链胰岛素,其包含通过6-11个氨基酸的连接肽连接的B和A链或经修饰的B和A链。 单链胰岛素将具有与人胰岛素相似或更低的生物胰岛素活性和IGF-1受体亲和力,并具有高的物理稳定性。 单链胰岛素可以在连接肽中含有至少一个碱性氨基酸残基。 单链胰岛素也可以在一个或多个Lys残基中酰化。

    Stable formulations of amylin and its analogues
    8.
    发明授权
    Stable formulations of amylin and its analogues 失效
    胰岛淀粉样多肽及其类似物的稳定制剂

    公开(公告)号:US08404645B2

    公开(公告)日:2013-03-26

    申请号:US12676970

    申请日:2008-09-11

    申请人: Morten Schlein

    发明人: Morten Schlein

    IPC分类号: A61K38/16

    摘要: The invention relates to a soluble pharmaceutical composition for parenteral administration, which comprises an amylin peptide and an anionic surfactant, and methods for treatment of hyperglycemia.

    摘要翻译: 本发明涉及一种肠胃外给药的可溶性药物组合物,其包含胰岛淀粉样多肽和阴离子表面活性剂,以及治疗高血糖症的方法。